Infliximab therapy for aggressive mooren ulceration.
Saw
Valerie P J
VP
Cornelius
Neil
N
Salama
Alan D
AD
Pusey
Charles
C
Lightman
Susan L
SL
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D009883:Ophthalmic Solutions; D014409:Tumor Necrosis Factor-alpha; D016572:Cyclosporine; D000069285:Infliximab